SRL Diagnostics launches ‘Heart Assure Test’ to predict risk of cardiac event
Patients with moderate or elevated risk in the test should immediately consult a cardiologist for further diagnosis and workup
Patients with moderate or elevated risk in the test should immediately consult a cardiologist for further diagnosis and workup
Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune
EBITDA stood at Rs. 39.9 crore and EBITDA margin for the quarter was 38.2% whereas Profit After Tax (PAT) stood at Rs. 17.5 crore translating into a PAT margin of 16.7%
The news report stating Krsnaa Diagnostics has accepted Rs 100 crores of undisclosed income is incorrect and baseless.
The tenure of contract will be upto 10 years from date of signing the contract/installation.
Lupin Diagnostics will equip doctors with accurate diagnosis in the patient journey by leveraging innovative technologies
An algorithm based testing for Fatty Liver Disease
Krsnaa Diagnostics now has its footprints in Delhi.
TMA will leverage Syntegra's synthetic data engine to accelerate the building of predictive diagnostic algorithms
Expanding diagnostics footprint in East India
Subscribe To Our Newsletter & Stay Updated